CSN Login
Members Online: 10

NEXAVA failing lung mets symptomatic: what next?

Posts: 1
Joined: Nov 2005

anyone having success with clinical trials?

Female, Asian, 65, primary HCC diagnosed Nov 2011

1) greyish white liver mass, 7.5x6 cm, adjacent to capsular, with 10+ satelite lesions, ranging 0.2 - 0.8 cm in diameter.  

2) also seen greyish white mass 5x5x4 cm with membrane, section face grey to brown in color, partially hemorragic.  Alongside gastric tissue measuring 4x2x1 cm. Suspected GIST

Diagnosis: right-side hepatocellular carcinoma, grade II - III with 2ndary lesions, sorrounding hepatic tissue G1S0; spleen and stomach interstitial stromal tumor suspected. 


Treatment history

Nov 18, 2011 - surgery.  Section VI, VII, VIII and partial diaphram resected, stomach partly removed due to GIST 

Nov 18, 2011 - TACE: EADM and Lipiodol 

Feb 7, 2012 - TACE.  Mets to both lungs.  Starting sorafenib, 800mg + 800mg per day

Jun 15, 2012 - TACE.  Stopped sorafenib

Aur 9, 2012 - TACE + BAI

Aug 16, 2012 - resuming sorafenib 800 mg + 400 mg per day



AFP 60500

CEA 2.17

CA19-9 9.4

AST 66

AP 84

GGT 174

Bile acid 52.0

bilirubin - slightly elevated, 22.4 total/ 7.4 conjugated

kidney function - normal, creatinine 45,micromol/L, eGFR 121

Subscribe with RSS
About Cancer Society

The content on this site is for informational purposes only. It is not a substitute for professional medical advice. Do not use this information to diagnose or treat a health problem or disease without consulting with a qualified healthcare provider. Please consult your healthcare provider with any questions or concerns you may have regarding your condition. Use of this online service is subject to the disclaimer and the terms and conditions.

Copyright 2000-2015 © Cancer Survivors Network